The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a ...

A ketamine-based nasal spray is officially the first and only ... The FDA first approved the Johnson & Johnson drug, called Spravato (esketamine), for some cases of depression in 2019, but it ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression ... report on Spravato (esketamine) and says the drug would need to be between 25% and 52% cheaper ...

But you should take doses of the nasal corticosteroid or nasal decongestant at least 1 hour before you receive a dose of Spravato. In studies of Spravato, the nasal decongestant oxymetazoline was ...

Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...

This is because the Food and Drug Administration (FDA ... S-ketamine, or esketamine (Spravato), is an FDA-approved nasal spray that doctors and healthcare professionals may prescribe for major ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic reactions in patients who weigh between 15 and 30 kilograms, the company said on ...

The UK agency declined to recommend NHS funding for Spravato (esketamine) nasal spray in 2020 – following ... convinced by the clinical data for the drug and believed it was not cost-effective.

Medicare doesn’t currently cover ketamine infusions for mental health conditions, as the Food and Drug Administration ... also called esketamine (Spravato), is a nasal spray with FDA approval ...